Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
IVVD Invivyd Inc
- Stocks
- Healthcare
- NASDAQ: IVVD
Price (delayed)
$0.7351
Market cap
$88.18M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.2
Enterprise value
$41M
Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has
Highlights
Invivyd's debt has decreased by 49% YoY and by 31% QoQ
The revenue is up by 45% from the previous quarter
The quick ratio has plunged by 78% YoY and by 12% from the previous quarter
Invivyd's equity has plunged by 70% YoY and by 20% from the previous quarter
Key stats
What are the main financial stats of IVVD
Market
Valuations
Earnings
Shares outstanding
119.96M
Market cap
$88.18M
Enterprise value
$41M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.63
Price to sales (P/S)
2.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.12
Revenue
$36.69M
Gross profit
$34.24M
Operating income
-$147.71M
Net income
-$142.72M
EBIT
-$142.72M
EBITDA
-$139.39M
Free cash flow
-$141.55M
Per share
Balance sheet
Liquidity
EPS
-$1.2
EPS diluted
-$1.2
Free cash flow per share
-$1.18
Book value per share
$0.45
Revenue per share
$0.31
TBVPS
$0.87
Total assets
$103.74M
Total liabilities
$49.6M
Debt
$894,000
Equity
$54.15M
Working capital
$26.23M
Debt to equity
0.02
Current ratio
1.53
Quick ratio
1.14
Net debt/EBITDA
0.34
Margins
Efficiency
Dividend
EBITDA margin
-379.9%
Gross margin
93.3%
Net margin
-389%
Operating margin
-402.6%
Return on assets
-99.7%
Return on equity
-165.2%
Return on invested capital
N/A
Return on capital employed
-263.6%
Return on sales
-389%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IVVD stock price
How has the Invivyd stock price performed over time
Intraday
1.67%
1 week
-7.99%
1 month
-23.93%
1 year
-33.17%
YTD
65.9%
QTD
2.81%
Financial performance
How have Invivyd's revenue and profit performed over time
Revenue
$36.69M
Gross profit
$34.24M
Operating income
-$147.71M
Net income
-$142.72M
Gross margin
93.3%
Net margin
-389%
The revenue is up by 45% from the previous quarter
The gross profit has grown by 44% from the previous quarter
Invivyd's net margin has increased by 42% QoQ
IVVD's operating margin is up by 42% since the previous quarter
Price vs fundamentals
How does IVVD's price correlate with its fundamentals
Growth
What is Invivyd's growth rate over time
Valuation
What is Invivyd stock price valuation
P/E
N/A
P/B
1.63
P/S
2.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.12
IVVD's EPS is up by 36% year-on-year and by 16% since the previous quarter
Invivyd's equity has plunged by 70% YoY and by 20% from the previous quarter
The price to book (P/B) is 48% higher than the last 4 quarters average of 1.1
IVVD's price to sales (P/S) is 87% lower than its last 4 quarters average of 18.1
The revenue is up by 45% from the previous quarter
Efficiency
How efficient is Invivyd business performance
IVVD's return on equity has dropped by 76% year-on-year and by 14% since the previous quarter
IVVD's return on sales is up by 42% since the previous quarter
The company's return on assets fell by 25% YoY
Dividends
What is IVVD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IVVD.
Financial health
How did Invivyd financials performed over time
Invivyd's total assets is 109% more than its total liabilities
The quick ratio has plunged by 78% YoY and by 12% from the previous quarter
IVVD's current ratio has plunged by 73% YoY and by 6% from the previous quarter
Invivyd's debt is 98% lower than its equity
Invivyd's debt to equity has surged by 100% YoY
Invivyd's equity has plunged by 70% YoY and by 20% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.